Skip to main content
Ghaith Abu Zeinah, MD, Hematology, New York, NY

GhaithFaridAbu ZeinahMD

Hematology • New York, NY

Hematologic Oncology, Myeloproliferative Disorder Hematology-Oncology

Instructor

Request Appointment

Overview of Dr. Abu Zeinah

Dr. Ghaith Abu Zeinah is a hematologist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital, New York-Presbyterian Hospital, and New York-Presbyterian Hospital. He received his medical degree from Weill Cornell Medical College in Qatar and has been in practice 3 years. He is one of 64 doctors at New York-Presbyterian Hospital and one of 64 doctors at New York-Presbyterian Hospital who specialize in Hematology. He also speaks multiple languages, including Arabic. He has more than 20 publications and over 400 citings.

Education & Training

  • New York Presbyterian Hospital (Cornell Campus)
    New York Presbyterian Hospital (Cornell Campus)Fellowship, Hematology and Medical Oncology, 2016 - 2019
  • New York Presbyterian Hospital (Cornell Campus)
    New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 2013 - 2016
  • Weill Cornell Medical College in Qatar
    Weill Cornell Medical College in QatarClass of 2013

Certifications & Licensure

  • NJ State Medical License
    NJ State Medical License 2023 - 2025
  • NY State Medical License
    NY State Medical License 2016 - 2025
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • Susan Murphy Fellow Award Weill Cornell Medicine, New York, NY, 2018
  • Fellows Award in Research Department of Medicine, Weill Cornell Medicine, 2018
  • Best Overall Abstract Award 11th International Congress on Myeloproliferative Neoplasms, 2018
  • Join now to see all

Publications & Presentations

PubMed

Abstracts/Posters

  • Molecular Genetics and Prognosis in Younger Patients with Chronic Lymphocytic Leukemia (CLL)
    Ghaith Abu Zeinah, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Thrombotic Risk Factors, Antithrombotic Therapy, and Outcomes of Asymptomatic Carriers of Antiphospholipid Antibodies and Patients with Antiphospholipid Syndrome
    Ghaith Abu-Zeinah, MD, Clara Oromendia, MS and Maria Teresa De Sancho, MD, American Society of Hematology, Atlanta, GA, 12/10/2017
  • A Single Institutional Experience Comparing Cryoprecipitate to Plasma in Patients with Disseminated Intravascular Coagulopathy (DIC) from Acute Myeloid Leukemia (AML)
    Ghaith Abu-Zeinah, MD, Mustafa Al-Kawaaz, MD, Valery J Li, MD, Yen-Michael S. Hsu, MD, PhD, Melissa M. Cushing, MD and Joseph Scandura, MD, PhD, American Society of Hematology, Atlanta, GA, 12/9/2017

Research History

  • Research FellowIdentifying therapeutic mechanisms in classical Myeloproliferative Neoplasms using an in vitro stem cell expansion platform2017 - 2019
  • Co-investigatorTransition of Care for Patients with Venous Thromboembolism (VTE) at ATHN Affiliated Sites2016 - 2018

Professional Memberships

Other Languages

  • Arabic

Dr. Ghaith Abu Zeinah, Dr. Ghaith Abu Zeinah, MD, Dr. G Abu Zeinah, Dr. Ghaith Farid Abu Zeinah